Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Jeff Clark: Gold Bull Market Running, These Stocks...

July 19, 2025

Crypto Market Recap: Crypto Rallies As “Big, Beautiful...

July 5, 2025

Allied Critical Metals Announces Corporate Update

May 17, 2025

Nuvau Minerals Completes High Resolution Drone MAG Survey

May 13, 2025

Syntheia Provides Telemarketer Services for Political Campaign in...

April 12, 2025

WOA receives R&D Tax Rebate

March 27, 2025

Maverick Metals Secures US$19 Million to Fast Track...

April 9, 2025

Large High Grade Rubidium Resource Identified at Seymour

July 24, 2025

Top 5 Small-cap Biotech Stocks of 2025

April 2, 2025

China’s Mineral Export Ban Reinforces Electric Royalties’ Long-Term...

May 14, 2025